Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.01 per share which beat the analyst consensus estimate of $1.94 by 3.72 percent. This is unchanged from the same period last year. The company reported quarterly sales of $7.082 billion which beat the analyst consensus estimate of $6.940 billion by 2.04 percent. This is a 1.84 percent increase over sales of $6.954 billion the same period last year.